Immunotherapy of chronic fatigue syndrome: Therapeutic interventions aimed at modulating the Th1/Th2 cytokine expression balance

Journal of Chronic Fatigue Syndrome

Volumn 8, Issue 1, 2001, Pages 3-37

  Patarca Montero, R ^a   Klimas, N G ^a   Fletcher, M A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Lymph node; Vaccine; Viruses

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GINSENG EXTRACT; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; SCHIZOPHYLLAN; SHI QUAN DA BU TANG; STAPHYLOCOCCUS VACCINE; STAPHYPAN BERNA;

B LYMPHOCYTE; CHRONIC FATIGUE SYNDROME; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; REVIEW;

EID: 0035067582     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/j092v08n01_02     Document Type: Review

References (191)

1. Chronic fatigue syndrome: A working case definition
2. Chronic fatigue syndrome
3. A chronic illness characterized by fatigue, neurologic and immunologic disorders and active human herpesvirus 6 type infection
4. A psychological assessment of chronic fatigue syndrome/chronic Epstein-Barr virus patients
5. Relationships of cognitive difficulties, depression and illness burden in chronic fatigue syndrome
6. The chronic fatigue syndrome: A comprehensive approach to its definition and study
7. Chronic fatigue syndrome and psychoneuroimmunology
8. Concurrent sick building syndrome and chronic fatigue syndrome
9. Viruses and chronic fatigue syndrome: Current status
10. Psychological stress and susceptibility to the common cold
11. Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome
12. Stress-associated immune modulation: Implications for infectious diseases?
13. Did Cook's sailors have Tapanui flu?-Chronic fatigue syndrome on the resolution
14. Anxiety disorders: A result of Long-term chronic fatigue-The psychiatric characteristics of the sufferers of Iceland disease
15. Enterovirus infections in new disguise
16. Evidence for enteroviral persistence in humans
17. Are echoviruses still orphan?
18. Post viral fatigue syndrome: Persistence of enterovirus RNA in muscle and elevated creatinine kinase
19. Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome
20. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome
21. No findings of enteroviruses in Swedish patients with chronic fatigue syndrome
22. Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue syndrome
23. Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome
24. Evidence for active Epstein-Barr virus infection in patients with persistent unexplained illnesses; elevated anti-early antigen antibodies
25. Chronic fatigue syndrome and diagnostic utility of antibody to Epstein-Barr virus early antigen
26. The relationship between fatigue, psycological and immunological variables in acute infectious illness
27. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever
28. MMPI profiles of patients with chronic fatigue syndrome
29. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome
30. Human herpesvirus 6
31. Development and application of HHV-6 antigen capture assay for the detection of HHV-6 infections
32. High prevalence without reactivation of herpes virus 6 in subjects with chronic fatigue syndrome
33. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population
34. Propagation and characterization of human herpesvirus-7 (HHV-7) isolates in a continuous T-lymphoblastoid cell line (SUPT1)
35. Cellular sequences in stealth viruses
36. Detection of RNA sequences in cultures of a stealth virus isolated form the cerebrospinal fluid of a health care worker with chronic fatigue syndrome. Case report
37. Severe stealth virus encephalopathy following chronic-fatigue-syndrome-like illness: Clinical and histopathological features
38. Genetic instability and fragmentation of a stealth viral genome
39. Multilab retrovirus test results for CFS patients from 3 different geographical areas
40. Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome
41. Electron microscope immunocytological profiles in chronic fatigue syndrome
42. Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: Case history and review
43. The relationship between fatigue, psychological and immunological variables in acute infectious illness
44. Pathogenesis of Borna disease
45. Borna disease virus infection and affective disorders in man
46. Detection of Borna disease virus (BDV) antibodies and BDV RNA psychiatric patients: Evidence of high sequence conservation of human blood-derived RNA
47. Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorders
48. Demonstration on borna disease virus in patients with chronic fatigue syndrome
49. Possible correlation between borna disease virus infection and Japanese patients with chronic fatigue syndrome
50. Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome
51. Borna disease virus proteins in patients with CFS
52. Lyme disease. Shift the paradigm
53. Lyme disease. Clinical and neurocognitive features of the post Lyme syndrome
54. Memory functioning in Lyme borreliosis
55. A case from practice (343). Chronic fatigue syndrome following Lyme borreliosis
56. Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences
57. Role of rickettsiae and chlamydiae in the psychopathology of chronic fatigue syndrome (CFS) patients: A diagnostic and therapeutic report
58. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome
59. Diagnosis and treatment of mycoplasmal infections in fibromyalgia and chronic fatigue syndromes: Relationship to Gulf War Illness
60. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome
61. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis and M. penetrans in patients with chronic fatigue syndrome, fibromyalgia, rheumatoid arthritis and Gulf War illness
62. Role of mycoplasmal infections in fatigue illnesses: Chronic fatigue and fibromyalgia syndromes, Gulf War illness, and rheumatoid arthritis
63. Common clinical and biological windows on CFS and rickettsial diseases
64. Au sujet des maladies Rickettsiennes
65. The Rickettsial approach of CFS
66. CFS in incline village
67. Origine des maladies Rickettsiennes
68. CFS: May 12: F. Nightingale's birthday: A comprehensive approach
69. Lymphomatic subpopulations in peripheral blood of sheep experimentally infected with tick-borne disease
70. Rickettsial Infection
71. Post Q fever syndrome
72. Post-infection fatigue syndrome following Q fever
73. The relationship between fatigue, psychological and immunological variables in acute infectious illness
74. Cytokine dysregulation in the post-Q-fever fatigue syndrome
75. To whom it may concern
76. The Rickettsial approach of CFS
77. Yersinia enterocolitica and the chronic fatigue syndrome
78. Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy)
79. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus
80. Antibodies to retroviral proteins and reverse transcriptase activity in patients with essential cryoglobulinemia
81. Serum antibody to retroviral gag proteins in systemic sclerosis
82. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV
83. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: A possible autoantigen for HTLV-I gag reactive autoantibodies
84. Identification of human immunodeficiency virus hybridizing sequences in the peripheral blood of a patient with systemic lupus erythematosus
85. Retrovirus-like sequences in Graves disease: Implications for human autoimmunity
86. Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease
87. Autoreactivity in HIV-1 infection: The role of molecular mimicry
88. Cellular immunity to a determinant common in glutamate decarboxylase and coxsackievirus in insulin-dependent diabetes
89. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele
90. Coxsackievirus and diabetes revisited
91. Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins
92. Antisulfatide IgG antibodies recognize HIV proteins
93. Autoantibodies to nuclear antigens in chronic fatigue syndrome
94. Fatigue syndromes and the aetiology of autoimmune disease
95. High frequency of autoantibodies in patients with chronic fatigue syndrome
96. Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome
97. Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus
98. Chronic Epstein-Barr virus infection
99. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: Elevated anti-early antigen antibodies
100. Liver extract-folic acid-cyanocobalamin vs. placebo for chronic fatigue syndrome
101. Naloxone-reversible monocyte dysfunction in patients with chronic fatigue syndrome
102. Sporadic postinfectious neuromyasthenia
103. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection
104. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr infection
105. Clinical laboratory test findings in patients with chronic fatigue syndrome
106. Chronic fatigue. A prospective clinical and virologic study
107. The postviral fatigue syndrome-An analysis of the findings in 50 cases
108. Thyroiditis and "chronic infectious mononucleosis"
109. Antimuscle and anti-CNS circulating antibodies in chronic fatigue syndrome
110. Chronic fatigue syndrome-A controlled cross sectional study
111. Antinuclear antibodies in children with chronic nonspecific complaints
112. Three cases of dermatomyositis erroneously diagnosed as "chronic fatigue syndrome"
113. "Seronegative" Sjoegren's syndrome manifested as a subset of chronic fatigue syndrome
114. Fatigue in primary Sjogren's syndrome
115. The female patient with faints and fatigue: Don't forget Sjogren's syndrome
116. Fatigue in lupus is not correlated with disease activity
117. Fatigue in ankylosing spondylitis: Its prevalence and relationship to disease activity, sleep, and other factors
118. The prevalence and meaning of fatigue in rheumatic disease
119. Predictors of subjective fatigue among individuals with rheumatoid arthritis
120. Fatigue in rheumatoid arthritis: The role of self-efficacy and problematic social support
121. The experience of rheumatoid arthritis pain and fatigue: Examining momentary reports and correlates over one week
122. Measles and atopy in Guinea-Bissau
123. Assumptions and contradictions in measles and measles immunization research: Is meales good for something?
124. Non-specific beneficial effect of measles immunisation: Analysis of mortality studies from developing countries
125. Enhancement of interleukin-4 production by pertussis toxin
126. Antigen based therapies to prevent diabetes in NOD mice
127. Induction of primate TH2 lymphokines to suppress TH1 cells
128. Lack of association between pertussis vaccine and symptoms of asthma and allergy
129. Pertussis vaccination and asthma: Is there a link?
130. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major
131. The role of TNF-alpha in T-cell mediated inflammation depends on the Th1/Th2 cytokine balance
132. Adaptation to chronic stress in military trainees. Adrenal androgens, testosterone, glucocorticoids, IGF-1, and immune function
133. Regulation of corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets
134. Induction of major histocompatibility complex class II glycoproteins by interferon gamma: Attenation of the effects of restraint stress
135. Alterations in central cathecolamines associated with immune responses in adult and aged mice
136. The immune response evokes changes in brain noradrenergic neurons
137. Sympathico-adrenal system activity in a primary immune response
138. The central nervous system and immunity
139. Immunological and neuroendocrine responses of rats to prolonged or repeated stress
140. Chronic variable stress facilitates tumoral growth: Reversal by imipramine administration
141. A prospective study of depression and immune dysregulation in multiple sclerosis
142. Corticotropin-releasing factor and interleukin-1 receptors in the brain-endocrine-immune axis. Role in stress response and infection
143. Stress-induced immune suppression. Role of the autonomic nervous system
144. Widespread activation and consequences of interleukin-1 in the brain
145. Depression and immunity: A meta-analytic review
146. Reduction of immune function in life stress and depression
147. Major depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity
148. Major depressive disorder: Role of age, sex, severity and hospitalization
149. Distal colon motility and clinical parameters in depression
150. Distal colon motility as a predictor of antidepressant response to fenfluramine, imipramine and clomipramine
151. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative
152. Reversal of age-associated decline in immune response to Pnu-immune vaccine by supplementation with the steroid hormone dehydroepiandrosterone
153. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
154. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4
155. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function
156. Steroids as regulators of the mammalian immune response
157. Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells
158. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells
159. Influence of cytokines and cellular interactions on the glucocorticoid-induced Ig (E, G, A, M) synthesis of peripheral blood mononuclear cells
160. Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils
161. Steroid hormone regulation of a polyclonal TH2 immune response
162. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes
163. Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: Effect of glucocorticoid therapy
164. Immune response reduced by intense intellectual stress: Change in lymphocyte proliferation in medical students
165. Stress-associated modulation of proto-oncogene expression in human peripheral blood leukocytes
166. Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: Differential responses of Mycobacterium bovis-BCG-resistant and -susceptible mice
167. The pathogenesis of tuberculosis
168. The Koch phenomenon and the immunopathology of tuberculosis
169. Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11 beta-hydroxysteroid dehydrogenase: A model for 11-HSD I deficiency
170. The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles
171. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression
172. Neurosteroids: Molecular mechanisms of action and psychopharmacological significance
173. Inhibition of interleukin 2 driven proliferation of mouse CTLL2 cells, by selected carbamate and organophosphate insecticides and congeners of carbaryl
174. International plan focuses on eradication of polio and containment of the virus
175. Clinical impact of adoptive therapy with purified CD8 cells in HIV infection
176. Ex vivo CD8 lymphocyte activation, expansion and reinfusion into donors with rIL-2-a phase I study
177. Changes in the clinical and immunological staff of AIDS patients upon adoptive therapy with activated autologous CD8+ T cells and interleukin-2 infusion
178. Immunomodulation with autologous, ex vivo manipulated cytotoxic T lymphocytes in HIV-1 disease
179. CD8 T-cell immunotherapy in AIDFS: Rationale and lessons learned at the cellular and molecular biology levels
180. Adoptive CD8 + T-cell immunotherapy of AIDS patients with Kaposi's sarcoma
181. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients
182. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia
183. Herbal remedies: Adverse effects and drug interactions
184. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions
185. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng
186. Siberian ginseng toxicity may be case of mistaken identity
187. Probable false authentication of herbal plants: Ginseng
188. Juzen-taiho-to, a Japanese herbal medicine, modulates type 1 and type 2 T-cell responses in old BALB/c mice